{"id":"https://openalex.org/W4320032523","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.01.023","title":"[The Efficacy and Safety of Daratumumab-Based Regimen in Treatment of Multiple Myeloma Patients with Renal Impairment].","display_name":"[The Efficacy and Safety of Daratumumab-Based Regimen in Treatment of Multiple Myeloma Patients with Renal Impairment].","publication_year":2023,"publication_date":"2023-02-01","ids":{"openalex":"https://openalex.org/W4320032523","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.01.023","pmid":"https://pubmed.ncbi.nlm.nih.gov/36765491"},"language":"en","primary_location":{"id":"pmid:36765491","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.01.023","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36765491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhongguo shi yan xue ye xue za zhi","raw_type":"English Abstract"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079871249","display_name":"Lingling Yin","orcid":"https://orcid.org/0000-0002-0922-7135","observed_orcids":["https://orcid.org/0000-0002-0922-7135"]},"institutions":[{"id":"https://openalex.org/I4210106614","display_name":"Affiliated Hospital of Xuzhou Medical College","ror":"https://ror.org/011xhcs96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ling-Ling Yin","raw_affiliation_strings":["Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210106614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013057771","display_name":"Yang-Ling Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105400","display_name":"The First People's Hospital of Changzhou","ror":"https://ror.org/01gaj0s81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105400"]},{"id":"https://openalex.org/I4405254887","display_name":"Suzhou University","ror":"https://ror.org/02bz8aa76","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405254887"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang-Ling Shen","raw_affiliation_strings":["Department of Hematology, The Third Affiliated Hospital of Suzhou University(The First People's Hospital of Changzhou), Changzhou 213003, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Third Affiliated Hospital of Suzhou University(The First People's Hospital of Changzhou), Changzhou 213003, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210105400","https://openalex.org/I4405254887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025140950","display_name":"Fengling Min","orcid":"https://orcid.org/0000-0002-6418-5206","observed_orcids":["https://orcid.org/0000-0002-6418-5206"]},"institutions":[{"id":"https://openalex.org/I4210137355","display_name":"Northern Jiangsu People's Hospital","ror":"https://ror.org/04gz17b59","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210137355"]},{"id":"https://openalex.org/I78978612","display_name":"Yangzhou University","ror":"https://ror.org/03tqb8s11","country_code":"CN","type":"education","lineage":["https://openalex.org/I78978612"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feng-Ling Min","raw_affiliation_strings":["Department of Hematology, The Affiliated Hospital of Yangzhou University, Yangzhou 225009, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Affiliated Hospital of Yangzhou University, Yangzhou 225009, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210137355","https://openalex.org/I78978612"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101586828","display_name":"Weiying Gu","orcid":"https://orcid.org/0000-0003-4913-1610","observed_orcids":["https://orcid.org/0000-0003-4913-1610"]},"institutions":[{"id":"https://openalex.org/I4210105400","display_name":"The First People's Hospital of Changzhou","ror":"https://ror.org/01gaj0s81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105400"]},{"id":"https://openalex.org/I4405254887","display_name":"Suzhou University","ror":"https://ror.org/02bz8aa76","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405254887"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei-Ying Gu","raw_affiliation_strings":["Department of Hematology, The Third Affiliated Hospital of Suzhou University(The First People's Hospital of Changzhou), Changzhou 213003, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Third Affiliated Hospital of Suzhou University(The First People's Hospital of Changzhou), Changzhou 213003, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210105400","https://openalex.org/I4405254887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110651305","display_name":"Ying Wang","orcid":"https://orcid.org/0000-0002-7607-7202","observed_orcids":["https://orcid.org/0000-0002-7607-7202","https://orcid.org/0009-0009-2862-7036"]},"institutions":[{"id":"https://openalex.org/I4210106614","display_name":"Affiliated Hospital of Xuzhou Medical College","ror":"https://ror.org/011xhcs96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ying Wang","raw_affiliation_strings":["Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210106614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073709637","display_name":"Kunming Qi","orcid":"https://orcid.org/0000-0002-0717-9133","observed_orcids":["https://orcid.org/0000-0002-0717-9133"]},"institutions":[{"id":"https://openalex.org/I4210106614","display_name":"Affiliated Hospital of Xuzhou Medical College","ror":"https://ror.org/011xhcs96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kun-Ming Qi","raw_affiliation_strings":["Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210106614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100330758","display_name":"Zhenyu Li","orcid":"https://orcid.org/0000-0003-4610-9135","observed_orcids":["https://orcid.org/0000-0003-4610-9135"]},"institutions":[{"id":"https://openalex.org/I4210106614","display_name":"Affiliated Hospital of Xuzhou Medical College","ror":"https://ror.org/011xhcs96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhen-Yu Li","raw_affiliation_strings":["Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China","institution_ids":["https://openalex.org/I4210106614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100666262","display_name":"Kailin Xu","orcid":"https://orcid.org/0000-0003-1375-1084","observed_orcids":["https://orcid.org/0000-0003-1375-1084"]},"institutions":[{"id":"https://openalex.org/I4210106614","display_name":"Affiliated Hospital of Xuzhou Medical College","ror":"https://ror.org/011xhcs96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106614"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kai-Lin Xu","raw_affiliation_strings":["Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China,E-mail: limd@163.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China,E-mail: limd@163.com","institution_ids":["https://openalex.org/I4210106614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2057,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.48829924,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"31","issue":"1","first_page":"141","last_page":"147"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7739999890327454},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.8109999895095825},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.996999979019165},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7620000243186951},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.7350000143051147},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8489999771118164},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.890999972820282}],"concepts":[{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.9551049470901489},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8534629940986633},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6805015802383423},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6322863698005676},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6237755417823792},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6132535338401794},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5642030835151672},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4666692316532135},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.44414424896240234},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4223382771015167},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.40389055013656616},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3939240574836731},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2116277515888214}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:36765491","doi":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.01.023","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36765491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhongguo shi yan xue ye xue za zhi","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4417014908","https://openalex.org/W2985372883","https://openalex.org/W3214323946","https://openalex.org/W2988033936","https://openalex.org/W3096336916","https://openalex.org/W4389258294","https://openalex.org/W4402360384","https://openalex.org/W4310108486","https://openalex.org/W3135943210","https://openalex.org/W4381469475"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"the":[3,64,155,177,203],"efficacy":[4,199],"and":[5,61,63,67,106,131,159,191,200],"safety":[6,201],"of":[7,11,24,76,87,94,102,109,115,123,129,134,139,152,162,205],"daratumumab":[8,50,52,57],"in":[9,40,202],"treatment":[10,169,204],"multiple":[12,206],"myeloma":[13,207],"(MM)":[14],"patients":[15,27,78,164,208],"with":[16,28,49,54,59,79,170,209],"renal":[17,116,141,210],"impairment":[18],"(RI).":[19],"METHODS:":[20],"The":[21,113],"clinical":[22],"data":[23],"15":[25],"MM":[26,80],"RI":[29],"who":[30],"received":[31],"daratumumab-based":[32,171],"regimen":[33],"from":[34],"January":[35],"2021":[36],"to":[37],"March":[38],"2022":[39],"three":[41],"centers":[42],"were":[43,47,69,165,186],"retrospectively":[44],"analyzed.":[45,70],"Patients":[46],"treated":[48],"or":[51,56],"combined":[53,58],"dexamethasone":[55,62],"bortezomib":[60],"curative":[65],"effect":[66],"survival":[68,158,161],"RESULTS:":[71],").":[72],"Overall":[73],"response":[74,90,98,104,111,117,125,142],"rate":[75,114],"11":[77],"was":[81,118,143,176],"91%":[82],"(\u2265MR),":[83],"including":[84,120],"1":[85,127],"case":[86,128],"stringent":[88],"complete":[89,124],"(sCR),":[91],"2":[92],"cases":[93,101,108,122,133],"very":[95],"good":[96,197],"partial":[97,103],"(VGPR),":[99],"3":[100,153],"(PR)":[105],"4":[107,121,132],"minor":[110],"(MR).":[112],"60%(9/15),":[119],"(CR),":[126],"PR":[130],"MR.":[135],"A":[136],"median":[137,150,156],"time":[138],"optimal":[140],"21":[144],"(ranged":[145],"7-56)":[146],"days.":[147],"With":[148],"a":[149],"follow-up":[151],"months,":[154],"progression-free":[157],"overall":[160],"all":[163],"not":[166],"reached.":[167],"After":[168],"regimen,":[172],"grade":[173],"1-2":[174],"neutropenia":[175],"most":[178],"common":[179],"hematological":[180],"adverse":[181,184,189],"reaction.":[182],"Non-hematological":[183],"reactions":[185,190],"mainly":[187],"infusion-related":[188],"infections.":[192],"CONCLUSION:":[193],"Daratumumab-based":[194],"regimens":[195],"have":[196],"short-term":[198],"impairment.":[211]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2023-02-12T00:00:00"}